Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD
Isabell Brikell(Aarhus University), Søren Dalsgaard(Lundbeck Foundation), Anita Thapar(Centre for Mental Health), Andrew J. Schork(University of California, San Diego), Anders D. Børglum(Aarhus University), Thomas Werge(Sankt Hans Hospital), Esben Agerbo(Lundbeck Foundation), Sonja LaBianca(Mental Health Services), Clara Albiñana(Lundbeck Foundation), Bjarni J. Vilhjálmsson(Broad Institute), Emil M. Pedersen(Lundbeck Foundation), David M. Hougaard(Statens Serum Institut), Preben Bo Mortensen(Aarhus University), Ditte Demontis(Broad Institute), Theresa Wimberley(Lundbeck Foundation), Ole Mors(Aarhus University)
Cited by 29
Related Papers
Identification of common genetic risk variants for autism spectrum disorder
|Nature Genetics|2019|2.6k
Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder
|Nature Genetics|2018|2.3k
Depression in adolescence
|The Lancet|2012|2.3k
Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection
|Nature Genetics|2018|1.7k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k